AMG
71
2
WDC
61
-4
LB
69
59
AVB
45
3
COST
44
-3
CA
9
-3
HPE
63
2
MTCH
53
2
D
48
3
FDX
48
-2
DG
40
-2
HCA
44
-4
EXR
37
6
MAC
47
4
PEP
41
-7
AON
62
2
TRIP
66
3
MCK
52
2
AMT
46
4
NAVI
49
2
AMG
71
2
WDC
61
-4
LB
69
59
AVB
45
3
COST
44
-3
CA
9
-3
HPE
63
2
MTCH
53
2
D
48
3
FDX
48
-2
DG
40
-2
HCA
44
-4
EXR
37
6
MAC
47
4
PEP
41
-7
AON
62
2
TRIP
66
3
MCK
52
2
AMT
46
4
NAVI
49
2
Financhill
Back

Cellectar Biosciences 10K Form

Sell
7

CLRB
Cellectar Biosciences

Last Price:
$5.02
Seasonality Move:
-13.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLRB News And Ratings

See the #1 stock for the next 7 days that we like better than CLRB

CLRB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-9.4M
Price / Cash Flow: 0
Annual Sales: $5.03
Price / Book: 1.18

Profitability

EPS (TTM): -21.90000
Net Income (TTM): $-24.5M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Cellectar Biosciences Earnings Forecast

Key Cellectar Biosciences Financial Ratios

  • Per Share Earnings over the last 20 years have been positive in 16 years.

Cellectar Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLRB
CUSIP: 15117F
Website: cellectar.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLRB Technical Analysis vs Fundamental Analysis

Sell
7
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy or a Sell?